Source: Washington Post
by Jay Bhattacharya, director, National Institutes of Health
“The mRNA platform is promising technology. I do not dispute its potential. In the future, it may yet deliver breakthroughs in treating diseases such as cancer, and HHS is continuing to invest in ongoing research on applications in oncology and other complex diseases. But as a vaccine intended for broad public use, especially during a public health emergency, the platform has failed a crucial test: earning public trust. No matter how elegant the science, a platform that lacks credibility among the people it seeks to protect cannot fulfill its public health mission.” (08/12/25)
https://www.washingtonpost.com/opinions/2025/08/12/nih-mrna-vaccines-jay-bhattacharya/